Press "Enter" to skip to content

TAT-11: Intraperitoneal Alpha-emitting Radio Immunotherapy with Astatine-211 in Relapsed Ovarian Cancer: Long term Follow-up with Individual Absorbed Dose Estimations – UroToday

admin 0

TAT-11: Intraperitoneal Alpha-emitting Radio Immunotherapy with Astatine-211 in Relapsed Ovarian Cancer: Long term Follow-up with Individual Absorbed Dose Estimations  UroToday

TAT 11 relapsed epithelial ovarian cancer treated with At211-MX35.

“ovarian cancer” – Google News

(Visited 2 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *